Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patients

BACKGROUND: Pancreatic adenocarcinoma is one of the most lethal tumors in the world with a poor prognosis. Thus, an accurate prediction model, which identify patients within high risk of pancreatic adenocarcinoma is needed to adjust the treatment and elevate the prognosis of these patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Chen, Jionghuang, Yu, Weihua, Huang, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503173/
https://www.ncbi.nlm.nih.gov/pubmed/37710166
http://dx.doi.org/10.1186/s12876-023-02916-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503173/
https://www.ncbi.nlm.nih.gov/pubmed/37710166
http://dx.doi.org/10.1186/s12876-023-02916-y

Ejemplares similares